Insights & Publications
Research Library
Explore in-depth articles, studies and analysis from our research team.
Cognitive Peptides: Semax, Selank & Brain Health Research
Cognitive peptides Semax and Selank: mechanism of action, BDNF modulation, GABA signalling, and published research overview. Research chemicals for CNS investigation.
Reta Peptide (Retatrutide): Triple Agonist Research Guide
Reta peptide (retatrutide) adds glucagon receptor to GIP/GLP-1 agonism. Phase 2 trial data, triple receptor mechanism, GIP+GLP-1+GCGR research guide.
Where to Buy Ozempic Research: Semaglutide UK Guide
Searching to buy Ozempic? Ozempic is a branded POM requiring a prescription. Pure Grade Labs supplies research-grade semaglutide for laboratory research only.
Semaglutide Research: Beyond Ozempic — Metabolic Mechanism
Semaglutide (Ozempic) GLP-1 receptor deep dive: molecular structure, SUSTAIN/STEP trials, CNS satiety signalling, tirzepatide comparison. For research.
Tirzepatide Research: Beyond Mounjaro — Dual Agonist Deep Dive
Beyond Mounjaro: tirzepatide's dual GIP + GLP-1 receptor agonism — deep dive into mechanism, SURPASS/SURMOUNT data, vs semaglutide. Research only.
CJC1295 (CJC-1295+DAC): Extended GH Release GHRH Analog
CJC1295 with DAC modification: how albumin binding extends half-life from 7 min to 6-8 days, 28-43% IGF-1 increase in Phase II trials. Full research overview with…
How Peptides Work: Mechanism of Action at the Cellular Level
How peptides work at the cellular level: receptor binding, GPCR signalling, second messengers, and downstream effects. Research-focused mechanism guide covering GH, GLP-1, and repair peptides.
HGH Frag: HGH Fragment 176-191 Research & Mechanism
HGH frag (HGH Fragment 176-191) is a 16-amino acid C-terminal peptide. Research shows selective beta-3 adrenergic activation in adipose tissue. Molecular weight 1817.1 Da. CAS 66004-57-7.…
AOD Peptide (AOD-9604): Selective Lipolysis Research
AOD-9604: 16-aa C-terminal GH fragment that activates beta-3 adrenergic receptors selectively. 900+ participants across METAOD trials. 2.6kg fat mass reduction vs 0.8kg placebo. Research overview.